Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 3
2006 3
2007 2
2008 3
2009 1
2010 1
2011 1
2012 4
2013 1
2014 9
2015 11
2016 5
2017 3
2018 2
2019 4
2020 3
2021 2
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced liver injury.
Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M, Lucena MI, Kaplowitz N, Aithal GP. Andrade RJ, et al. Among authors: merz m. Nat Rev Dis Primers. 2019 Aug 22;5(1):58. doi: 10.1038/s41572-019-0105-0. Nat Rev Dis Primers. 2019. PMID: 31439850 Free article. Review.
An electronic nematic liquid in BaNi2As2.
Yao Y, Willa R, Lacmann T, Souliou SM, Frachet M, Willa K, Merz M, Weber F, Meingast C, Heid R, Haghighirad AA, Schmalian J, Le Tacon M. Yao Y, et al. Among authors: merz m. Nat Commun. 2022 Aug 4;13(1):4535. doi: 10.1038/s41467-022-32112-7. Nat Commun. 2022. PMID: 35927267 Free PMC article.
Methodology to assess clinical liver safety data.
Merz M, Lee KR, Kullak-Ublick GA, Brueckner A, Watkins PB. Merz M, et al. Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S33-45. doi: 10.1007/s40264-014-0184-5. Drug Saf. 2014. PMID: 25352326 Free PMC article. Review.
Drug-induced liver injury: the dawn of biomarkers?
Weiler S, Merz M, Kullak-Ublick GA. Weiler S, et al. Among authors: merz m. F1000Prime Rep. 2015 Mar 3;7:34. doi: 10.12703/P7-34. eCollection 2015. F1000Prime Rep. 2015. PMID: 25926985 Free PMC article. Review.
A generic operational strategy to qualify translational safety biomarkers.
Matheis K, Laurie D, Andriamandroso C, Arber N, Badimon L, Benain X, Bendjama K, Clavier I, Colman P, Firat H, Goepfert J, Hall S, Joos T, Kraus S, Kretschmer A, Merz M, Padro T, Planatscher H, Rossi A, Schneiderhan-Marra N, Schuppe-Koistinen I, Thomann P, Vidal JM, Molac B. Matheis K, et al. Among authors: merz m. Drug Discov Today. 2011 Jul;16(13-14):600-8. doi: 10.1016/j.drudis.2011.04.011. Epub 2011 May 6. Drug Discov Today. 2011. PMID: 21570476 Review.
Bile acids in drug induced liver injury: Key players and surrogate markers.
Schadt HS, Wolf A, Pognan F, Chibout SD, Merz M, Kullak-Ublick GA. Schadt HS, et al. Among authors: merz m. Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):257-266. doi: 10.1016/j.clinre.2015.12.017. Epub 2016 Feb 10. Clin Res Hepatol Gastroenterol. 2016. PMID: 26874804 Free article. Review.
Next-Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development.
Roth SE, Avigan MI, Bourdet D, Brott D, Church R, Dash A, Keller D, Sherratt P, Watkins PB, Westcott-Baker L, Lentini S, Merz M, Ramaiah L, Ramaiah SK, Stanley AM, Marcinak J. Roth SE, et al. Among authors: merz m. Clin Pharmacol Ther. 2020 Feb;107(2):333-346. doi: 10.1002/cpt.1571. Epub 2019 Sep 14. Clin Pharmacol Ther. 2020. PMID: 31314926 Free PMC article. Review.
Investigative safety science as a competitive advantage for Pharma.
Moggs J, Moulin P, Pognan F, Brees D, Leonard M, Busch S, Cordier A, Heard DJ, Kammüller M, Merz M, Bouchard P, Chibout SD. Moggs J, et al. Among authors: merz m. Expert Opin Drug Metab Toxicol. 2012 Sep;8(9):1071-82. doi: 10.1517/17425255.2012.693914. Epub 2012 Jul 7. Expert Opin Drug Metab Toxicol. 2012. PMID: 22769724 Review.
61 results